<?xml version="1.0" encoding="UTF-8" ?><rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xml:lang="en">
<channel rdf:about="http://www.giiresearch.com/bio_report.shtml">
  <title>Market Research Reports for Biotechnology</title>
  <link>http://www.giiresearch.com/bio_report.shtml</link>
  <description>Market Research Reports for Biotechnology</description>
  <dc:publisher>Global Information, Inc.</dc:publisher>
  <dc:rights>(C) 2013 Global Information, Inc.</dc:rights>
  <dc:date>2013-05-20</dc:date>
  <sy:updatePeriod>daily</sy:updatePeriod>
  <items>
    <rdf:Seq>
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc92659-proteomics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231305-future-french-microbiology-testing-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231306-future-german-microbiology-testing-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231307-future-italian-microbiology-testing-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231308-future-japanese-microbiology-testing-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231309-future-spanish-microbiology-testing-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231310-future-uk-microbiology-testing-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231311-future-us-microbiology-testing-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231464-future-german-nucleic-acid-testing-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231466-future-japanese-nucleic-acid-testing-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231468-future-uk-nucleic-acid-testing-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231469-future-us-nucleic-acid-testing-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231626-future-french-tumor-marker-testing-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231627-future-italian-tumor-marker-testing-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231628-future-german-tumor-marker-testing-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231629-future-japanese-tumor-marker-testing-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231630-future-spanish-tumor-marker-testing-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231631-future-uk-tumor-marker-testing-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231632-future-us-tumor-marker-testing-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bf270379-market-primary-cells-stem-cell-derived-cells.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224810-future-german-molecular-diagnostics-market-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224812-future-japanese-molecular-diagnostics-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224814-future-uk-molecular-diagnostics-market-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224815-future-us-molecular-diagnostics-market-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237413-2012-france-cancer-diagnostics-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237414-2012-germany-cancer-diagnostics-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237415-2012-italy-cancer-diagnostics-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237416-2012-japan-cancer-diagnostics-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237417-2012-spain-cancer-diagnostics-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237418-2012-uk-cancer-diagnostics-market-outlook-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237419-2012-us-cancer-diagnostics-market-outlook-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237662-2012-france-clinical-chemistry-immunodiagnostics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237663-2012-germany-clinical-chemistry-immunodiagnostics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237664-2012-italy-clinical-chemistry-immunodiagnostics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237665-2012-japan-clinical-chemistry-immunodiagnostics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237666-2012-spain-clinical-chemistry-immunodiagnostics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237667-2012-uk-clinical-chemistry-immunodiagnostics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237668-2012-us-clinical-chemistry-immunodiagnostics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238087-2012-france-coagulation-market-outlook-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238088-2012-germany-coagulation-market-outlook-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238089-2012-italy-coagulation-market-outlook-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238090-2012-japan-coagulation-market-outlook-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238091-2012-spain-coagulation-market-outlook-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238092-2012-uk-coagulation-market-outlook-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238093-2012-us-coagulation-market-outlook-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238178-2012-france-hematology-flow-cytometry-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238179-2012-germany-hematology-flow-cytometry-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238180-2012-italy-hematology-flow-cytometry-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238181-2012-japan-hematology-flow-cytometry-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238182-2012-spain-hematology-flow-cytometry-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238183-2012-us-hematology-flow-cytometry-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238184-2012-uk-hematology-flow-cytometry-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi214250-immunoglobulins-market-2017-off-label-usage.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231623-leading-tumor-marker-suppliers-strategic.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238080-2012-global-diagnostic-imaging-companies-strategic.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/cei121988-generic-biosimilar.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kt235218-world-biological-drugs-market-2012-2022.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs270480-cell-culture-purchasing-trends.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/biof234291-mesenchymal-stem-cells-advances-applications.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/wild117615-clinical-stage.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/wild121841-pharma-bio-diagnost2.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/wild238158-cancer-monoclonal-antibody-partnering-terms.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/wild270198-antibiotics-partnering-terms-agreements.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/wild270199-discovery-preclinical-clinical-stage-partnering.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/tsm270510-computational-biology-market-global-industry.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/tsm269977-cell-culture-market-global-industry-analysis-size.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/infi123360-molecular.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/hts269952-outsourced-ion-channel-testing-trends.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/infi270592-global-biochips-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/amid81739-cn-autoimmune.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/amid86318-ch-antibiotics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/amid106810-ch-monoclonal-antibody.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/lmer146105-thera-protein-bio.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/tk203885-cancer-diagnostic-testing-world-markets.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/ida227848-us-market-dental-bone-graft-substitutes-dental.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fist203954-ips-cell-generation-patent-landscape-2011.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/wild230295-personalized-medicine-partnering-terms-agreements.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fist269662-ips-cell-differentiation-patent-landscape.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/pai269892-nucleic-acid-purification-dashboard-series-1-china.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd270247-medipoint-diagnostic-cardiac-biomarkers-acute.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd270248-medipoint-diagnostic-cardiac-biomarkers-acute.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd270249-medipoint-diagnostic-cardiac-biomarkers-acute.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd270250-medipoint-diagnostic-cardiac-biomarkers-acute.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd270251-medipoint-diagnostic-cardiac-biomarkers-acute.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc63671-electropho-tech.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc269538-immunoassays-technologies-global-markets-focus-on.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kl217055-cell-culture-world-market-media-sera-reagents-3rd.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166026-antibodi-pepti-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166037-cancer-thera-antibo.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166078-peptides-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166080-onco-protein-kinase.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg167148-androgen-recept.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg167159-antibodies-in-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg167162-b-cell-receptor.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg167164-biologicals-in-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171744-cytokine-therapy.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171745-egfr1-signaling.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171746-gene-therapy.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171748-hedgehog-signal-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171750-id-signaling-p-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171751-il1-signaling-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171752-il2-signaling-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171753-il-3-signaling.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171754-il-4-signaling.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171755-il5-signaling-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171756-il-6-signaling.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171757-il-7-signaling.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171758-il-9-signaling.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171759-immunotherapy.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171761-kit-receptor.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171769-notch-signaling.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171770-nucleic-acid.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171783-peptides-oncology.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171785-protein-kinase.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171786-proteins-oncology.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171788-radiation-therapy.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171790-rna-interference.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171791-t-cell-receptor-signal.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171792-tgf-beta-rece-signal.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171793-tnf-alpha-signal.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171794-wnt-signaling.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg227316-analytical-tool-apoptosis-oncology.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg251307-cancer-stem-cells-drug-pipeline-update.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc269017-immunoassays-technologies-global-markets-focus-on.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc269018-immunoassays-technologies-global-markets-focus-on.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc269019-immunoassays-technologies-global-markets-focus-on.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/tsm269111-biotechnology-market-by-application-by-technology.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238120-2012-france-flow-cytometry-market-outlook-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238121-2012-germany-flow-cytometry-market-outlook-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238122-2012-italy-flow-cytometry-market-outlook-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238123-2012-japan-flow-cytometry-market-outlook-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238124-2012-spain-flow-cytometry-market-outlook-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238125-2012-uk-flow-cytometry-market-outlook-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238126-2012-us-flow-cytometry-market-outlook-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/infi269613-global-chiral-technology-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/infi269614-global-proteomics-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg233488-2012-european-cancer-diagnostics-market-france.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg234158-2012-european-clinical-chemistry-immunodiagnostics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg234159-2012-european-flow-cytometry-market-france-germany.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238086-2012-european-coagulation-market-outlook-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238432-2012-european-nucleic-acid-testing-market-france.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238433-2012-european-tumor-marker-testing-market-france.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238434-2012-european-microbiology-testing-market-france.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg250416-future-horizons-european-hematology-flow-cytometry.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc268909-bioinformatics-technologies-global-markets.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237644-2012-global-afp-diagnostics-market-outlook-test.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237645-2012-global-beta-2-microglobulin-diagnostics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237646-2012-global-ca-tumor-markers-diagnostics-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237648-2012-global-occult-blood-diagnostics-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237649-2012-global-prostatic-acid-phosphatase-diagnostics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237650-2012-global-pap-smear-hpv-diagnostics-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237651-2012-global-psa-diagnostics-market-outlook-test.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237652-2012-global-diagnostics-market-outlook-cell.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238095-2012-global-alpha-2-antiplasmin-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238096-2012-global-antithrombin-iii-market-outlook-test.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238097-2012-global-d-dimer-market-outlook-test-volume.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238098-2012-global-factor-assays-market-outlook-test.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238099-2012-global-fibrinogen-market-outlook-test-volume.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238100-2012-global-heparin-market-outlook-test-volume.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238101-2012-global-proteins-c-s-market-outlook-test.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238102-2012-global-pt-testing-market-outlook-test-volume.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg238103-2012-global-thrombin-time-market-outlook-test.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/hts217789-qpcr-assay-trends-2010.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/yd265543-biophotonics-market-focus-on-life-sciences-health.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc268719-immunoassays-technologies-global-markets-focus-on.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc268720-immunoassays-technologies-global-markets-focus-on.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/wild229876-biomarker-partnering-terms-agreements.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/wild230289-companion-diagnostics-partnering-terms-agreements.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/wild230291-pharmacogenomics-partnering-terms-agreements.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/es208889-molecular-imaging-market-coming-age.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/ren204217-global-molecular-diagnostics-market-future.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi226429-seasonal-influenza-vaccine-market-asia-pacific.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc268466-immunoassays-technologies-global-markets.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs268424-us-qpcr-reagents-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/tk203890-molecular-diagnostics-cancer-testing.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70915-diagnostics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70916-cell-therapy.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70918-proteomics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70919-neuroprotection.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70921-transdermal.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70922-animal-bio.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70924-medicine.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70928-drug-deli.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70930-rnai.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70931-gene-therapy.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70933-nanobio.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70934-central-nervous.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70936-cardiovascular.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70937-biomarkers.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70938-cytogenetics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70939-therapeutics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai84243-dna-sequ-tech.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai136243-biochips.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/biof234290-capitalizing-on-opportunities-cord-blood-industry.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/mama265103-protein-engineering-market-products-monoclonal.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/mama265105-biomaterials-market-by-products-polymers-metals.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/lmer265036-antibody-technologies-attrition-rates-industry.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc136786-central-nerv-sys-biomark.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/cd264963-advances-clinical-genome-sequencing-diagnostics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc264964-histone-methyltransferases-global-markets-research.html" />
    </rdf:Seq>
  </items>
</channel>
<item rdf:about="http://www.giiresearch.com/report/bc92659-proteomics.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:date>2013-05-17</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Proteomics: Technologies and Global Markets</title>
  <link>http://www.giiresearch.com/report/bc92659-proteomics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231305-future-french-microbiology-testing-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-05-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>French Microbiology Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg231305-future-french-microbiology-testing-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231306-future-german-microbiology-testing-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-05-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>German Microbiology Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg231306-future-german-microbiology-testing-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231307-future-italian-microbiology-testing-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-05-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Italian Microbiology Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg231307-future-italian-microbiology-testing-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231308-future-japanese-microbiology-testing-market.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-05-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Japanese Microbiology Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg231308-future-japanese-microbiology-testing-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231309-future-spanish-microbiology-testing-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-05-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Spanish Microbiology Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg231309-future-spanish-microbiology-testing-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231310-future-uk-microbiology-testing-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-05-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>UK Microbiology Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg231310-future-uk-microbiology-testing-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231311-future-us-microbiology-testing-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-05-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>US Microbiology Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg231311-future-us-microbiology-testing-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231464-future-german-nucleic-acid-testing-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>German Nucleic Acid Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg231464-future-german-nucleic-acid-testing-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231466-future-japanese-nucleic-acid-testing-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Japanese Nucleic Acid Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg231466-future-japanese-nucleic-acid-testing-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231468-future-uk-nucleic-acid-testing-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>UK Nucleic Acid Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg231468-future-uk-nucleic-acid-testing-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231469-future-us-nucleic-acid-testing-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>US Nucleic Acid Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg231469-future-us-nucleic-acid-testing-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231626-future-french-tumor-marker-testing-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>French Tumor Marker Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg231626-future-french-tumor-marker-testing-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231627-future-italian-tumor-marker-testing-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Italian Tumor Marker Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg231627-future-italian-tumor-marker-testing-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231628-future-german-tumor-marker-testing-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>German Tumor Marker Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg231628-future-german-tumor-marker-testing-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231629-future-japanese-tumor-marker-testing-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Japanese Tumor Marker Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg231629-future-japanese-tumor-marker-testing-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231630-future-spanish-tumor-marker-testing-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Spanish Tumor Marker Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg231630-future-spanish-tumor-marker-testing-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231631-future-uk-tumor-marker-testing-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>UK Tumor Marker Testing Market Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg231631-future-uk-tumor-marker-testing-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231632-future-us-tumor-marker-testing-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>US Tumor Marker Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg231632-future-us-tumor-marker-testing-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bf270379-market-primary-cells-stem-cell-derived-cells.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:date>2013-05-17</dc:date>
  <dc:creator>BioInformatics, LLC</dc:creator>
  <title>The Market for Primary Cells &amp; Stem Cell-Derived Cells: Current and Future Opportunities</title>
  <link>http://www.giiresearch.com/report/bf270379-market-primary-cells-stem-cell-derived-cells.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224810-future-german-molecular-diagnostics-market-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>German Molecular Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg224810-future-german-molecular-diagnostics-market-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224812-future-japanese-molecular-diagnostics-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Japanese Molecular Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg224812-future-japanese-molecular-diagnostics-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224814-future-uk-molecular-diagnostics-market-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>UK Molecular Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg224814-future-uk-molecular-diagnostics-market-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224815-future-us-molecular-diagnostics-market-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>US Molecular Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg224815-future-us-molecular-diagnostics-market-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237413-2012-france-cancer-diagnostics-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>French Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237413-2012-france-cancer-diagnostics-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237414-2012-germany-cancer-diagnostics-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>German Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237414-2012-germany-cancer-diagnostics-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237415-2012-italy-cancer-diagnostics-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Italian Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237415-2012-italy-cancer-diagnostics-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237416-2012-japan-cancer-diagnostics-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Japanese Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237416-2012-japan-cancer-diagnostics-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237417-2012-spain-cancer-diagnostics-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Spanish Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237417-2012-spain-cancer-diagnostics-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237418-2012-uk-cancer-diagnostics-market-outlook-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>UK Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237418-2012-uk-cancer-diagnostics-market-outlook-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237419-2012-us-cancer-diagnostics-market-outlook-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>US Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237419-2012-us-cancer-diagnostics-market-outlook-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237662-2012-france-clinical-chemistry-immunodiagnostics.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>French Clinical Chemistry and Immunodiagnostic Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237662-2012-france-clinical-chemistry-immunodiagnostics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237663-2012-germany-clinical-chemistry-immunodiagnostics.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>German Clinical Chemistry and Immunodiagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237663-2012-germany-clinical-chemistry-immunodiagnostics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237664-2012-italy-clinical-chemistry-immunodiagnostics.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Italian Clinical Chemistry and Immunodiagnostic Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237664-2012-italy-clinical-chemistry-immunodiagnostics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237665-2012-japan-clinical-chemistry-immunodiagnostics.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Japanese Clinical Chemistry and Immunodiagnostic Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237665-2012-japan-clinical-chemistry-immunodiagnostics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237666-2012-spain-clinical-chemistry-immunodiagnostics.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Spanish Clinical Chemistry and Immunodiagnostic Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237666-2012-spain-clinical-chemistry-immunodiagnostics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237667-2012-uk-clinical-chemistry-immunodiagnostics.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>UK Clinical Chemistry and Immunodiagnostic Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237667-2012-uk-clinical-chemistry-immunodiagnostics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237668-2012-us-clinical-chemistry-immunodiagnostics.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>US Clinical Chemistry and Immunodiagnostic Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237668-2012-us-clinical-chemistry-immunodiagnostics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238087-2012-france-coagulation-market-outlook-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>French Coagulation Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg238087-2012-france-coagulation-market-outlook-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238088-2012-germany-coagulation-market-outlook-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>German Coagulation Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg238088-2012-germany-coagulation-market-outlook-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238089-2012-italy-coagulation-market-outlook-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Italian Coagulation Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg238089-2012-italy-coagulation-market-outlook-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238090-2012-japan-coagulation-market-outlook-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Japanese Coagulation Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg238090-2012-japan-coagulation-market-outlook-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238091-2012-spain-coagulation-market-outlook-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Spanish Coagulation Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg238091-2012-spain-coagulation-market-outlook-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238092-2012-uk-coagulation-market-outlook-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>UK Coagulation Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg238092-2012-uk-coagulation-market-outlook-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238093-2012-us-coagulation-market-outlook-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>US Coagulation Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg238093-2012-us-coagulation-market-outlook-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238178-2012-france-hematology-flow-cytometry-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>French Hematology and Flow Cytometry Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg238178-2012-france-hematology-flow-cytometry-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238179-2012-germany-hematology-flow-cytometry-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>German Hematology and Flow Cytometry Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg238179-2012-germany-hematology-flow-cytometry-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238180-2012-italy-hematology-flow-cytometry-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Italian Hematology and Flow Cytometry Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg238180-2012-italy-hematology-flow-cytometry-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238181-2012-japan-hematology-flow-cytometry-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Japanese Hematology and Flow Cytometry Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg238181-2012-japan-hematology-flow-cytometry-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238182-2012-spain-hematology-flow-cytometry-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Spanish Hematology and Flow Cytometry Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg238182-2012-spain-hematology-flow-cytometry-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238183-2012-us-hematology-flow-cytometry-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>US Hematology and Flow Cytometry Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg238183-2012-us-hematology-flow-cytometry-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238184-2012-uk-hematology-flow-cytometry-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>UK Hematology and Flow Cytometry Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg238184-2012-uk-hematology-flow-cytometry-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi214250-immunoglobulins-market-2017-off-label-usage.html">
  <dc:language>en</dc:language>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-05-14</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for Alzheimer's Disease</title>
  <link>http://www.giiresearch.com/report/gbi214250-immunoglobulins-market-2017-off-label-usage.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231623-leading-tumor-marker-suppliers-strategic.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-14</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>CompetitiveWatch Tumor Markers: Strategic Assessments of Major Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg231623-leading-tumor-marker-suppliers-strategic.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238080-2012-global-diagnostic-imaging-companies-strategic.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-05-14</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>CompetitiveWatch Diagnostic Imaging: Leading Suppliers Strategic Directions</title>
  <link>http://www.giiresearch.com/report/vpg238080-2012-global-diagnostic-imaging-companies-strategic.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/cei121988-generic-biosimilar.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2013-05-13</dc:date>
  <dc:creator>Cutting Edge Information</dc:creator>
  <title>Post-Patent Generic and Biosimilar Defense Strategies: Harnessing Competitive Tactics to Mitigate Revenue Erosion</title>
  <link>http://www.giiresearch.com/report/cei121988-generic-biosimilar.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kt235218-world-biological-drugs-market-2012-2022.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-05-13</dc:date>
  <dc:creator>Visiongain</dc:creator>
  <title>World Biological Drugs Market 2013-2023</title>
  <link>http://www.giiresearch.com/report/kt235218-world-biological-drugs-market-2012-2022.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs270480-cell-culture-purchasing-trends.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:date>2013-05-13</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Cell Culture Purchasing Trends</title>
  <link>http://www.giiresearch.com/report/fs270480-cell-culture-purchasing-trends.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/biof234291-mesenchymal-stem-cells-advances-applications.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:date>2013-05-12</dc:date>
  <dc:creator>BIOINFORMANT WORLDWIDE, LLC</dc:creator>
  <title>Mesenchymal Stem Cells - Advances &amp; Applications</title>
  <link>http://www.giiresearch.com/report/biof234291-mesenchymal-stem-cells-advances-applications.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/wild117615-clinical-stage.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:date>2013-05-08</dc:date>
  <dc:creator>Current Partnering, a division of Wildwood Ventures Limited</dc:creator>
  <title>Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech</title>
  <link>http://www.giiresearch.com/report/wild117615-clinical-stage.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/wild121841-pharma-bio-diagnost2.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-05-08</dc:date>
  <dc:creator>Current Partnering, a division of Wildwood Ventures Limited</dc:creator>
  <title>Discovery Stage Partnering Terms and Agreements in Pharma and Biotech</title>
  <link>http://www.giiresearch.com/report/wild121841-pharma-bio-diagnost2.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/wild238158-cancer-monoclonal-antibody-partnering-terms.html">
  <dc:language>en</dc:language>
  <dc:subject>Biologics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:date>2013-05-08</dc:date>
  <dc:creator>Current Partnering, a division of Wildwood Ventures Limited</dc:creator>
  <title>Cancer Monoclonal Antibody Partnering Terms and Agreements</title>
  <link>http://www.giiresearch.com/report/wild238158-cancer-monoclonal-antibody-partnering-terms.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/wild270198-antibiotics-partnering-terms-agreements.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-05-08</dc:date>
  <dc:creator>Current Partnering, a division of Wildwood Ventures Limited</dc:creator>
  <title>Antibiotics Partnering Terms and Agreements</title>
  <link>http://www.giiresearch.com/report/wild270198-antibiotics-partnering-terms-agreements.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/wild270199-discovery-preclinical-clinical-stage-partnering.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:date>2013-05-08</dc:date>
  <dc:creator>Current Partnering, a division of Wildwood Ventures Limited</dc:creator>
  <title>Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech</title>
  <link>http://www.giiresearch.com/report/wild270199-discovery-preclinical-clinical-stage-partnering.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/tsm270510-computational-biology-market-global-industry.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:date>2013-05-07</dc:date>
  <dc:creator>Transparency Market Research</dc:creator>
  <title>Computational Biology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018</title>
  <link>http://www.giiresearch.com/report/tsm270510-computational-biology-market-global-industry.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/tsm269977-cell-culture-market-global-industry-analysis-size.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:date>2013-05-06</dc:date>
  <dc:creator>Transparency Market Research</dc:creator>
  <title>Cell Culture Market-Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018</title>
  <link>http://www.giiresearch.com/report/tsm269977-cell-culture-market-global-industry-analysis-size.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/infi123360-molecular.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-03</dc:date>
  <dc:creator>Infiniti Research Limited  (Technavio)</dc:creator>
  <title>Global Molecular Diagnostics Market 2012-2016</title>
  <link>http://www.giiresearch.com/report/infi123360-molecular.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/hts269952-outsourced-ion-channel-testing-trends.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:date>2013-05-03</dc:date>
  <dc:creator>HTStec Ltd</dc:creator>
  <title>Outsourced Ion Channel Testing Trends 2013</title>
  <link>http://www.giiresearch.com/report/hts269952-outsourced-ion-channel-testing-trends.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/infi270592-global-biochips-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:date>2013-05-03</dc:date>
  <dc:creator>Infiniti Research Limited  (Technavio)</dc:creator>
  <title>Global Biochips Market 2012-2016</title>
  <link>http://www.giiresearch.com/report/infi270592-global-biochips-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/amid81739-cn-autoimmune.html">
  <dc:language>en</dc:language>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>Asia Market Information &amp; Development</dc:creator>
  <title>Autoimmune Drugs Markets in China</title>
  <link>http://www.giiresearch.com/report/amid81739-cn-autoimmune.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/amid86318-ch-antibiotics.html">
  <dc:language>en</dc:language>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>Asia Market Information &amp; Development</dc:creator>
  <title>Antibiotics Markets in China</title>
  <link>http://www.giiresearch.com/report/amid86318-ch-antibiotics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/amid106810-ch-monoclonal-antibody.html">
  <dc:language>en</dc:language>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>Asia Market Information &amp; Development</dc:creator>
  <title>Monoclonal Antibody Markets in China</title>
  <link>http://www.giiresearch.com/report/amid106810-ch-monoclonal-antibody.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/lmer146105-thera-protein-bio.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>La Merie Publishing</dc:creator>
  <title>Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters &amp; Biosuperiors</title>
  <link>http://www.giiresearch.com/report/lmer146105-thera-protein-bio.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/tk203885-cancer-diagnostic-testing-world-markets.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>Trimark Publications</dc:creator>
  <title>Cancer Diagnostic Testing World Markets</title>
  <link>http://www.giiresearch.com/report/tk203885-cancer-diagnostic-testing-world-markets.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/ida227848-us-market-dental-bone-graft-substitutes-dental.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomaterials</dc:subject>
  <dc:subject>Dental Equipment</dc:subject>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>iData Research Inc.</dc:creator>
  <title>U.S. Dental Bone Graft Substitutes and Other Biomaterials Market</title>
  <link>http://www.giiresearch.com/report/ida227848-us-market-dental-bone-graft-substitutes-dental.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fist203954-ips-cell-generation-patent-landscape-2011.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:date>2013-04-30</dc:date>
  <dc:creator>France Innovation Scientifique et Transfert (FIST SA)</dc:creator>
  <title>iPS cell Generation patent landscape - 2013</title>
  <link>http://www.giiresearch.com/report/fist203954-ips-cell-generation-patent-landscape-2011.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/wild230295-personalized-medicine-partnering-terms-agreements.html">
  <dc:language>en</dc:language>
  <dc:subject>Personalized Medicine</dc:subject>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:date>2013-04-30</dc:date>
  <dc:creator>Current Partnering, a division of Wildwood Ventures Limited</dc:creator>
  <title>Personalized Medicine Partnering Terms and Agreements</title>
  <link>http://www.giiresearch.com/report/wild230295-personalized-medicine-partnering-terms-agreements.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fist269662-ips-cell-differentiation-patent-landscape.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:date>2013-04-30</dc:date>
  <dc:creator>France Innovation Scientifique et Transfert (FIST SA)</dc:creator>
  <title>iPS cell Differentiation patent landscape 2013</title>
  <link>http://www.giiresearch.com/report/fist269662-ips-cell-differentiation-patent-landscape.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/pai269892-nucleic-acid-purification-dashboard-series-1-china.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-30</dc:date>
  <dc:creator>Percepta Associates Inc.</dc:creator>
  <title>2013 Nucleic Acid Purification Dashboard Series 1 - China</title>
  <link>http://www.giiresearch.com/report/pai269892-nucleic-acid-purification-dashboard-series-1-china.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd270247-medipoint-diagnostic-cardiac-biomarkers-acute.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-04-30</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - Current and Future Players</title>
  <link>http://www.giiresearch.com/report/gd270247-medipoint-diagnostic-cardiac-biomarkers-acute.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd270248-medipoint-diagnostic-cardiac-biomarkers-acute.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-04-30</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - EU Analysis and Market Forecasts</title>
  <link>http://www.giiresearch.com/report/gd270248-medipoint-diagnostic-cardiac-biomarkers-acute.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd270249-medipoint-diagnostic-cardiac-biomarkers-acute.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-04-30</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - US Analysis and Market Forecasts</title>
  <link>http://www.giiresearch.com/report/gd270249-medipoint-diagnostic-cardiac-biomarkers-acute.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd270250-medipoint-diagnostic-cardiac-biomarkers-acute.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-04-30</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts</title>
  <link>http://www.giiresearch.com/report/gd270250-medipoint-diagnostic-cardiac-biomarkers-acute.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd270251-medipoint-diagnostic-cardiac-biomarkers-acute.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-04-30</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - South America Analysis and Market Forecasts</title>
  <link>http://www.giiresearch.com/report/gd270251-medipoint-diagnostic-cardiac-biomarkers-acute.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bc63671-electropho-tech.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-26</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Electrophoresis Technology: Global Markets</title>
  <link>http://www.giiresearch.com/report/bc63671-electropho-tech.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bc269538-immunoassays-technologies-global-markets-focus-on.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-25</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Immunoassays: Technologies and Global Markets -- Focus on Infectious Disease Immunoassays</title>
  <link>http://www.giiresearch.com/report/bc269538-immunoassays-technologies-global-markets-focus-on.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kl217055-cell-culture-world-market-media-sera-reagents-3rd.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:date>2013-04-24</dc:date>
  <dc:creator>Kalorama Information</dc:creator>
  <title>Cell Culture: The Market for Media, Sera and Reagents, 5th Edition</title>
  <link>http://www.giiresearch.com/report/kl217055-cell-culture-world-market-media-sera-reagents-3rd.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166026-antibodi-pepti-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Biologics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Antibodies and Peptides in Oncology</title>
  <link>http://www.giiresearch.com/report/bg166026-antibodi-pepti-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166037-cancer-thera-antibo.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Cancer Therapeutic Antibodies</title>
  <link>http://www.giiresearch.com/report/bg166037-cancer-thera-antibo.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166078-peptides-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Peptides in Oncology</title>
  <link>http://www.giiresearch.com/report/bg166078-peptides-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166080-onco-protein-kinase.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Molecular Targeted Therapeutics</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Protein Kinase Inhibitors in Oncology</title>
  <link>http://www.giiresearch.com/report/bg166080-onco-protein-kinase.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg167148-androgen-recept.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg167148-androgen-recept.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg167159-antibodies-in-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Antibodies in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg167159-antibodies-in-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg167162-b-cell-receptor.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg167162-b-cell-receptor.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg167164-biologicals-in-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Biologicals in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg167164-biologicals-in-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171744-cytokine-therapy.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Cytokine Therapy in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171744-cytokine-therapy.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171745-egfr1-signaling.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>EGFR1 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171745-egfr1-signaling.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171746-gene-therapy.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Gene Therapy in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171746-gene-therapy.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171748-hedgehog-signal-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Hedgehog Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171748-hedgehog-signal-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171750-id-signaling-p-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>ID Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171750-id-signaling-p-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171751-il1-signaling-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>IL-1 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171751-il1-signaling-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171752-il2-signaling-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>IL-2 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171752-il2-signaling-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171753-il-3-signaling.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>IL-3 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171753-il-3-signaling.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171754-il-4-signaling.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>IL-4 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171754-il-4-signaling.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171755-il5-signaling-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>IL-5 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171755-il5-signaling-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171756-il-6-signaling.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>IL-6 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171756-il-6-signaling.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171757-il-7-signaling.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>IL-7 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171757-il-7-signaling.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171758-il-9-signaling.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>IL-9 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171758-il-9-signaling.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171759-immunotherapy.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Immunotherapy in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171759-immunotherapy.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171761-kit-receptor.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Kit Receptor Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171761-kit-receptor.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171769-notch-signaling.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Notch Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171769-notch-signaling.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171770-nucleic-acid.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Nucleic Acid Therapies in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171770-nucleic-acid.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171783-peptides-oncology.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Peptides in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171783-peptides-oncology.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171785-protein-kinase.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Molecular Targeted Therapeutics</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Protein Kinase Inhibitors in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171785-protein-kinase.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171786-proteins-oncology.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Proteins in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171786-proteins-oncology.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171788-radiation-therapy.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Radiation Therapy in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171788-radiation-therapy.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171790-rna-interference.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>RNA Interference Therapy in Oncology Drug Pipeline Update 2012</title>
  <link>http://www.giiresearch.com/report/bg171790-rna-interference.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171791-t-cell-receptor-signal.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171791-t-cell-receptor-signal.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171792-tgf-beta-rece-signal.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>TGF-Beta Receptor Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171792-tgf-beta-rece-signal.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171793-tnf-alpha-signal.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>TNF-Alpha Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171793-tnf-alpha-signal.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171794-wnt-signaling.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Wnt Signaling Pathway in Oncology Drug Pipeline Update 2012</title>
  <link>http://www.giiresearch.com/report/bg171794-wnt-signaling.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg227316-analytical-tool-apoptosis-oncology.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Apoptosis in Oncology</title>
  <link>http://www.giiresearch.com/report/bg227316-analytical-tool-apoptosis-oncology.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg251307-cancer-stem-cells-drug-pipeline-update.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Cancer Stem Cells Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg251307-cancer-stem-cells-drug-pipeline-update.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bc269017-immunoassays-technologies-global-markets-focus-on.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Immunoassays: Technologies and Global Markets -- Focus on Radioimmunoassays</title>
  <link>http://www.giiresearch.com/report/bc269017-immunoassays-technologies-global-markets-focus-on.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bc269018-immunoassays-technologies-global-markets-focus-on.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Immunoassays: Technologies and Global Markets -- Focus on Diabetes Laboratory Immunoassays</title>
  <link>http://www.giiresearch.com/report/bc269018-immunoassays-technologies-global-markets-focus-on.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bc269019-immunoassays-technologies-global-markets-focus-on.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Immunoassays: Technologies and Global Markets -- Focus on Immunoassays for Drug Screening</title>
  <link>http://www.giiresearch.com/report/bc269019-immunoassays-technologies-global-markets-focus-on.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/tsm269111-biotechnology-market-by-application-by-technology.html">
  <dc:language>en</dc:language>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>Transparency Market Research</dc:creator>
  <title>Biotechnology Market by Application, by Technology - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2010 - 2017</title>
  <link>http://www.giiresearch.com/report/tsm269111-biotechnology-market-by-application-by-technology.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238120-2012-france-flow-cytometry-market-outlook-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-19</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the French Flow Cytometry Market:Emerging Opportunities, Supplier Shares, Country Forecasts,  Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg238120-2012-france-flow-cytometry-market-outlook-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238121-2012-germany-flow-cytometry-market-outlook-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-19</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the German Flow Cytometry Market:Emerging Opportunities, Supplier Shares, Country Forecasts,  Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg238121-2012-germany-flow-cytometry-market-outlook-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238122-2012-italy-flow-cytometry-market-outlook-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-19</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the Italian Flow Cytometry Market:Emerging Opportunities, Supplier Shares, Country Forecasts,  Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg238122-2012-italy-flow-cytometry-market-outlook-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238123-2012-japan-flow-cytometry-market-outlook-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-19</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the Japanese Flow Cytometry Market:Emerging Opportunities, Supplier Shares, Country Forecasts,  Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg238123-2012-japan-flow-cytometry-market-outlook-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238124-2012-spain-flow-cytometry-market-outlook-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-19</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the Spanish Flow Cytometry Market:Emerging Opportunities, Supplier Shares, Country Forecasts,  Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg238124-2012-spain-flow-cytometry-market-outlook-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238125-2012-uk-flow-cytometry-market-outlook-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-19</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the UK Flow Cytometry Market:Emerging Opportunities, Supplier Shares, Country Forecasts,  Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg238125-2012-uk-flow-cytometry-market-outlook-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238126-2012-us-flow-cytometry-market-outlook-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-19</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the US Flow Cytometry Market:Emerging Opportunities, Supplier Shares, Country Forecasts,  Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg238126-2012-us-flow-cytometry-market-outlook-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/infi269613-global-chiral-technology-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-19</dc:date>
  <dc:creator>Infiniti Research Limited  (Technavio)</dc:creator>
  <title>Global Chiral Technology Market 2012-2016</title>
  <link>http://www.giiresearch.com/report/infi269613-global-chiral-technology-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/infi269614-global-proteomics-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:date>2013-04-19</dc:date>
  <dc:creator>Infiniti Research Limited  (Technavio)</dc:creator>
  <title>Global Proteomics Market 2012-2016</title>
  <link>http://www.giiresearch.com/report/infi269614-global-proteomics-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg233488-2012-european-cancer-diagnostics-market-france.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-04-18</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the European Cancer Diagnostics Market: France, Germany, Italy, Spain, UK - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg233488-2012-european-cancer-diagnostics-market-france.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg234158-2012-european-clinical-chemistry-immunodiagnostics.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-04-18</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the European Clinical Chemistry and Immunodiagnostic Markets: France, Germany, Italy, Spain, UK - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg234158-2012-european-clinical-chemistry-immunodiagnostics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg234159-2012-european-flow-cytometry-market-france-germany.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-18</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the European Flow Cytometry Market: France, Germany, Italy, Spain, UK - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg234159-2012-european-flow-cytometry-market-france-germany.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238086-2012-european-coagulation-market-outlook-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-18</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the European Coagulation Testing Market: France, Germany, Italy, Spain, UK - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg238086-2012-european-coagulation-market-outlook-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238432-2012-european-nucleic-acid-testing-market-france.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-04-18</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the European Nucleic Acid Testing Market France, Germany, Italy, Spain, UK Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg238432-2012-european-nucleic-acid-testing-market-france.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238433-2012-european-tumor-marker-testing-market-france.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-04-18</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the European Tumor Marker Testing Market: France, Germany, Italy, Spain, UK - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg238433-2012-european-tumor-marker-testing-market-france.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238434-2012-european-microbiology-testing-market-france.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-18</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the European Microbiology Testing Market: France, Germany, Italy, Spain, UK - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg238434-2012-european-microbiology-testing-market-france.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg250416-future-horizons-european-hematology-flow-cytometry.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-18</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the European Hematology and Flow Cytometry Markets: France, Germany, Italy, Spain, UK - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg250416-future-horizons-european-hematology-flow-cytometry.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bc268909-bioinformatics-technologies-global-markets.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:date>2013-04-18</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Bioinformatics: Technologies and Global Markets</title>
  <link>http://www.giiresearch.com/report/bc268909-bioinformatics-technologies-global-markets.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237644-2012-global-afp-diagnostics-market-outlook-test.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the AFP Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg237644-2012-global-afp-diagnostics-market-outlook-test.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237645-2012-global-beta-2-microglobulin-diagnostics.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the Beta-2 Microglobulin Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg237645-2012-global-beta-2-microglobulin-diagnostics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237646-2012-global-ca-tumor-markers-diagnostics-market.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the CA Tumor Markers Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg237646-2012-global-ca-tumor-markers-diagnostics-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237648-2012-global-occult-blood-diagnostics-market.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the Occult Blood Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg237648-2012-global-occult-blood-diagnostics-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237649-2012-global-prostatic-acid-phosphatase-diagnostics.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the Prostatic Acid Phosphatase Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg237649-2012-global-prostatic-acid-phosphatase-diagnostics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237650-2012-global-pap-smear-hpv-diagnostics-market.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the Pap Smear/HPV Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg237650-2012-global-pap-smear-hpv-diagnostics-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237651-2012-global-psa-diagnostics-market-outlook-test.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the PSA Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg237651-2012-global-psa-diagnostics-market-outlook-test.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237652-2012-global-diagnostics-market-outlook-cell.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the Cell Surface Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg237652-2012-global-diagnostics-market-outlook-cell.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238095-2012-global-alpha-2-antiplasmin-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the Alpha-2 Antiplasmin Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg238095-2012-global-alpha-2-antiplasmin-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238096-2012-global-antithrombin-iii-market-outlook-test.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the Antithrombin III Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg238096-2012-global-antithrombin-iii-market-outlook-test.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238097-2012-global-d-dimer-market-outlook-test-volume.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the D-Dimer Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg238097-2012-global-d-dimer-market-outlook-test-volume.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238098-2012-global-factor-assays-market-outlook-test.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the Factor Assay Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg238098-2012-global-factor-assays-market-outlook-test.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238099-2012-global-fibrinogen-market-outlook-test-volume.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the Fibrinogen Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg238099-2012-global-fibrinogen-market-outlook-test-volume.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238100-2012-global-heparin-market-outlook-test-volume.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the Heparin Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg238100-2012-global-heparin-market-outlook-test-volume.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238101-2012-global-proteins-c-s-market-outlook-test.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the Proteins C and S Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg238101-2012-global-proteins-c-s-market-outlook-test.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238102-2012-global-pt-testing-market-outlook-test-volume.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the PT Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg238102-2012-global-pt-testing-market-outlook-test-volume.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg238103-2012-global-thrombin-time-market-outlook-test.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the Thrombin Time Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg238103-2012-global-thrombin-time-market-outlook-test.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/hts217789-qpcr-assay-trends-2010.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:date>2013-04-15</dc:date>
  <dc:creator>HTStec Ltd</dc:creator>
  <title>qPCR Assay Trends 2013</title>
  <link>http://www.giiresearch.com/report/hts217789-qpcr-assay-trends-2010.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/yd265543-biophotonics-market-focus-on-life-sciences-health.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-15</dc:date>
  <dc:creator>Yole Developpement</dc:creator>
  <title>Biophotonics market: Focus on Life Sciences &amp; Health Applications</title>
  <link>http://www.giiresearch.com/report/yd265543-biophotonics-market-focus-on-life-sciences-health.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bc268719-immunoassays-technologies-global-markets-focus-on.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-15</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Immunoassays: Technologies and Global Markets -- Focus on Enzyme Immunoassays</title>
  <link>http://www.giiresearch.com/report/bc268719-immunoassays-technologies-global-markets-focus-on.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bc268720-immunoassays-technologies-global-markets-focus-on.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-15</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Immunoassays: Technologies and Global Markets -- Focus on Fluorescent Immunoassays</title>
  <link>http://www.giiresearch.com/report/bc268720-immunoassays-technologies-global-markets-focus-on.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/wild229876-biomarker-partnering-terms-agreements.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-04-10</dc:date>
  <dc:creator>Current Partnering, a division of Wildwood Ventures Limited</dc:creator>
  <title>Biomarker Partnering Terms and Agreements</title>
  <link>http://www.giiresearch.com/report/wild229876-biomarker-partnering-terms-agreements.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/wild230289-companion-diagnostics-partnering-terms-agreements.html">
  <dc:language>en</dc:language>
  <dc:subject>Personalized Medicine</dc:subject>
  <dc:date>2013-04-10</dc:date>
  <dc:creator>Current Partnering, a division of Wildwood Ventures Limited</dc:creator>
  <title>Companion Diagnostics Partnering Terms and Agreements</title>
  <link>http://www.giiresearch.com/report/wild230289-companion-diagnostics-partnering-terms-agreements.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/wild230291-pharmacogenomics-partnering-terms-agreements.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:date>2013-04-10</dc:date>
  <dc:creator>Current Partnering, a division of Wildwood Ventures Limited</dc:creator>
  <title>Pharmacogenomics Partnering Terms and Agreements</title>
  <link>http://www.giiresearch.com/report/wild230291-pharmacogenomics-partnering-terms-agreements.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/es208889-molecular-imaging-market-coming-age.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Molecular Imaging/Agents</dc:subject>
  <dc:subject>Medical Imaging</dc:subject>
  <dc:date>2013-04-09</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>Advances in Molecular Imaging: A market coming of age</title>
  <link>http://www.giiresearch.com/report/es208889-molecular-imaging-market-coming-age.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/ren204217-global-molecular-diagnostics-market-future.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-04-08</dc:date>
  <dc:creator>Renub Research</dc:creator>
  <title>Molecular Diagnostics Market &amp; Forecast (By Application, Technology, Countries, Companies &amp; Clinical Trials) to 2017: Global Analysis</title>
  <link>http://www.giiresearch.com/report/ren204217-global-molecular-diagnostics-market-future.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi226429-seasonal-influenza-vaccine-market-asia-pacific.html">
  <dc:language>en</dc:language>
  <dc:subject>Vaccines</dc:subject>
  <dc:subject>Infectious Disease</dc:subject>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:date>2013-04-08</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants</title>
  <link>http://www.giiresearch.com/report/gbi226429-seasonal-influenza-vaccine-market-asia-pacific.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bc268466-immunoassays-technologies-global-markets.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2013-04-08</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Immunoassays: Technologies and Global Markets</title>
  <link>http://www.giiresearch.com/report/bc268466-immunoassays-technologies-global-markets.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs268424-us-qpcr-reagents-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:date>2013-04-04</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>U.S. qPCR Reagents Market</title>
  <link>http://www.giiresearch.com/report/fs268424-us-qpcr-reagents-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/tk203890-molecular-diagnostics-cancer-testing.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-04-02</dc:date>
  <dc:creator>Trimark Publications</dc:creator>
  <title>Molecular Diagnostics in Cancer Testing</title>
  <link>http://www.giiresearch.com/report/tk203890-molecular-diagnostics-cancer-testing.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70915-diagnostics.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:date>2013-04-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Molecular Diagnostics - Technologies, Markets and Companies</title>
  <link>http://www.giiresearch.com/report/jai70915-diagnostics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70916-cell-therapy.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:date>2013-04-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Cell Therapy - Technologies, Markets and Companies</title>
  <link>http://www.giiresearch.com/report/jai70916-cell-therapy.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70918-proteomics.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:date>2013-04-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Proteomics - Technologies, Markets and Companies</title>
  <link>http://www.giiresearch.com/report/jai70918-proteomics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70919-neuroprotection.html">
  <dc:language>en</dc:language>
  <dc:subject>Neurodegenerative Disease</dc:subject>
  <dc:date>2013-04-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Neuroprotection - Drugs, Markets and Companies</title>
  <link>http://www.giiresearch.com/report/jai70919-neuroprotection.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70921-transdermal.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Delivery System</dc:subject>
  <dc:date>2013-04-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Transdermal Drug Delivery - Technologies, Markets, and Companies</title>
  <link>http://www.giiresearch.com/report/jai70921-transdermal.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70922-animal-bio.html">
  <dc:language>en</dc:language>
  <dc:subject>Veterinary Medicine</dc:subject>
  <dc:date>2013-04-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Animal Biotechnology - Technologies, Markets and Companies</title>
  <link>http://www.giiresearch.com/report/jai70922-animal-bio.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70924-medicine.html">
  <dc:language>en</dc:language>
  <dc:subject>Personalized Medicine</dc:subject>
  <dc:date>2013-04-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Personalized Medicine - scientific &amp; commercial aspects</title>
  <link>http://www.giiresearch.com/report/jai70924-medicine.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70928-drug-deli.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Delivery System</dc:subject>
  <dc:date>2013-04-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Drug Delivery in Cancer - technologies, markets and companies</title>
  <link>http://www.giiresearch.com/report/jai70928-drug-deli.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70930-rnai.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:date>2013-04-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>RNAi - technologies, markets and companies</title>
  <link>http://www.giiresearch.com/report/jai70930-rnai.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70931-gene-therapy.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:date>2013-04-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Gene Therapy - technologies, markets and companies</title>
  <link>http://www.giiresearch.com/report/jai70931-gene-therapy.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70933-nanobio.html">
  <dc:language>en</dc:language>
  <dc:subject>Nanotechnology</dc:subject>
  <dc:date>2013-04-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Nanobiotechnologies- applications, markets and companies</title>
  <link>http://www.giiresearch.com/report/jai70933-nanobio.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70934-central-nervous.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Delivery System</dc:subject>
  <dc:subject>Neurodegenerative Disease</dc:subject>
  <dc:date>2013-04-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Drug Delivery in Central Nervous System Diseases - technologies, markets and companies</title>
  <link>http://www.giiresearch.com/report/jai70934-central-nervous.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70936-cardiovascular.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Delivery System</dc:subject>
  <dc:date>2013-04-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Cardiovascular Drug Delivery - technologies,markets and companies</title>
  <link>http://www.giiresearch.com/report/jai70936-cardiovascular.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70937-biomarkers.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-04-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Biomarkers - technologies,markets and companies</title>
  <link>http://www.giiresearch.com/report/jai70937-biomarkers.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70938-cytogenetics.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-04-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Cytogenetics - technologies,markets and companies</title>
  <link>http://www.giiresearch.com/report/jai70938-cytogenetics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70939-therapeutics.html">
  <dc:language>en</dc:language>
  <dc:subject>Biologics</dc:subject>
  <dc:subject>Infectious Disease</dc:subject>
  <dc:date>2013-04-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Antiviral Therapeutics - technologies, markets and companies</title>
  <link>http://www.giiresearch.com/report/jai70939-therapeutics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai84243-dna-sequ-tech.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:date>2013-04-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>DNA sequencing: technologies, markets and companies</title>
  <link>http://www.giiresearch.com/report/jai84243-dna-sequ-tech.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai136243-biochips.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-04-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Biochips - technologies,markets and companies</title>
  <link>http://www.giiresearch.com/report/jai136243-biochips.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/biof234290-capitalizing-on-opportunities-cord-blood-industry.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:date>2013-04-01</dc:date>
  <dc:creator>BIOINFORMANT WORLDWIDE, LLC</dc:creator>
  <title>Capitalizing on Opportunities in Cord Blood Industry Growth (2013 Version)</title>
  <link>http://www.giiresearch.com/report/biof234290-capitalizing-on-opportunities-cord-blood-industry.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/mama265103-protein-engineering-market-products-monoclonal.html">
  <dc:language>en</dc:language>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-03-28</dc:date>
  <dc:creator>Markets and Markets</dc:creator>
  <title>Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017</title>
  <link>http://www.giiresearch.com/report/mama265103-protein-engineering-market-products-monoclonal.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/mama265105-biomaterials-market-by-products-polymers-metals.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomaterials</dc:subject>
  <dc:date>2013-03-28</dc:date>
  <dc:creator>Markets and Markets</dc:creator>
  <title>Biomaterials Market [By Products (Polymers, Metals, Ceramics, Natural Biomaterials) &amp; Applications (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Ophthalmology, Neurology Disorders)] - Global Forecasts to 2017</title>
  <link>http://www.giiresearch.com/report/mama265105-biomaterials-market-by-products-polymers-metals.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/lmer265036-antibody-technologies-attrition-rates-industry.html">
  <dc:language>en</dc:language>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-03-26</dc:date>
  <dc:creator>La Merie Publishing</dc:creator>
  <title>Antibody Technologies and Attrition Rates - an industry analysis 2013</title>
  <link>http://www.giiresearch.com/report/lmer265036-antibody-technologies-attrition-rates-industry.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bc136786-central-nerv-sys-biomark.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Neurodegenerative Disease</dc:subject>
  <dc:date>2013-03-25</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Central Nervous System (CNS) Biomarkers: Technologies and Global Markets</title>
  <link>http://www.giiresearch.com/report/bc136786-central-nerv-sys-biomark.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/cd264963-advances-clinical-genome-sequencing-diagnostics.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:date>2013-03-25</dc:date>
  <dc:creator>Insight Pharma Reports</dc:creator>
  <title>Advances in Clinical Genome Sequencing and Diagnostics - Overview</title>
  <link>http://www.giiresearch.com/report/cd264963-advances-clinical-genome-sequencing-diagnostics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bc264964-histone-methyltransferases-global-markets-research.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-03-25</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Histone Methyltransferases: Global Markets for Research Tools, Diagnostics and Drug Discovery</title>
  <link>http://www.giiresearch.com/report/bc264964-histone-methyltransferases-global-markets-research.html</link>
  <description></description>
</item>
</rdf:RDF>